Zeitschrift fur Krebsforschung und Klinische Onkologie (ZKKO)

Zeitschrift für Krebsforschung und Klinische Onkologie is one of the oldest and most influential German journals dedicated to cancer research and oncology. Established in 1971, it has played a major role in documenting the evolution of cancer biology from early experimental studies to modern molecular oncology and clinical cancer treatment strategies. The journal publishes peer-reviewed original research articles, clinical studies, experimental tumor biology, and translational oncology research. Its scope covers tumor pathogenesis, genetic and molecular mechanisms of cancer development, cancer diagnostics, chemotherapy and radiotherapy approaches, immunotherapy, and targeted treatment strategies. Over the decades, the journal has served as a key platform for integrating laboratory-based cancer research with clinical oncology practice. It has contributed to significant advancements in understanding tumor growth, metastasis, and treatment resistance. The journal is widely indexed in international databases and continues to be an important publication in oncology research.

Zeitschrift fur Krebsforschung und Klinische Onkologie (ZKKO) is :-

• International, Peer-Reviewed, Open Access, Refereed, Oncology, cancer biology, tumor pathology, clinical oncology, radiotherapy, chemotherapy research, experimental cancer research, molecular oncology, translational cancer medicine, tumor pathogenesis, genetic and molecular mechanisms of cancer development, cancer diagnostics, chemotherapy and radiotherapy approaches, immunotherapy, targeted treatment strategies, It has contributed to significant advancements in understanding tumor growth, metastasis, treatment resistance , Online , Monthly Journal

• UGC Approved, ISSN Approved: P-ISSN E-ISSN: 0084-5353, Established: 1971,
• Does Not Provide Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE